Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: K. Bloomquist who wrote (32)	11/12/1997 12:39:00 PM
From: Paul K	Read Replies (1) \| Respond to of 288

Colorado MEDtech Inc. Announces First Quarter Results BOULDER, Colo.--(BW HealthWire)--Nov. 12, 1997--Colorado MEDtech Inc. (NASDAQ:CMED - news), a Boulder-based medical products and services company, today announced results for its first quarter ended Sept. 30, 1997. Net income in the first quarter increased to $663,709, an increase of 46%, compared to $453,333 in the same quarter last year and earnings per share were 6 cents per share compared to 5 cents per share in the same period last year. Sales in the first quarter were $7,260,230, an increase of 37%, compared to $5,288,302 in the same period last year. ''In spite of moving RELA's manufacturing operations to a new facility in Longmont, Colo., in August and the first quarter historically being our slowest quarter because of vacations, we are pleased with our first quarter results,'' said John V. Atanasoff, president and chief executive officer. ' 'This is our 17th consecutive quarter of profitable results.'' Colorado MEDtech Inc., through its wholly owned affiliates and operating divisions, is a leading full-service provider of advanced medical products and comprehensive outsourcing services. Colorado MEDtech Inc. Earnings Recap First Quarter Ended Sept. 30, 1997 Sept. 30, 1996 (unaudited) (unaudited) Sales & service $ 7,260,230 $ 5,288,302 Net income $ 663,709 $ 453,333 Net income per share Primary $ .06 $ .05 Fully diluted $ .06 $ .05 Wgt. avg. shares outstanding Primary 11,821,519 11,011,962 Fully diluted 11,995,048 11,011,962